• UK patients get early access to Akcea’s volanesorsen pharmatimes
    July 20, 2018
    Akcea Therapeutics’ volanesorsen will be available to eligible patients in the UK before it is officially licensed in the EU, having been granted entry to the country’s Early Access to Medicines Scheme.
PharmaSources Customer Service